Picture of Longduoduo Co logo

LDDD Longduoduo Co Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Momentum

Relative Strength (%)
1m-2.48%
3m-3.86%
6m-19.59%
1yr-24.36%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value150.07
Price to Tang. Book150.07
Price to Free Cashflown/a
Price to Sales29.99
EV to EBITDA143.34

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital80%
Return on Equity87.14%
Operating Margin18.01%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202530th Jun 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Longduoduo Co EPS forecast chart

Profile Summary

Longduoduo Co Ltd is a company principally engaged the provision of preventive care services. The Company provides solution for chronic disease problems through non-drug treatments and prevents cardiovascular and cerebrovascular diseases in advance. The Company offers health consultation and advice to customers and sells treatment services to customers, provided by Longduoduo to customers in local cooperative medical institutions. The Company's treatment projects mainly include ozone autologous blood transfusion (immunotherapy), Xingnao Tongluo therapy, double blood purification, platelet-rich plasma (PRP) injection therapy and others. The Company's products and services are mainly used for the prevention of myocardial infarction, cerebral infarction, hemiplegia, cardiovascular and cerebrovascular diseases. The Company mainly conduct its businesses in domestic market.

Directors

    Last Annual
    June 30th, 2024
    Last Interim
    March 31st, 2025
    Incorporated
    October 25th, 2021
    Public Since
    August 17th, 2022
    No. of Shareholders
    50
    No. of Employees
    49
    Sector
    Healthcare Providers & Services
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    30,015,036

    LDDD Share Price Performance

    Upcoming Events for LDDD

    Q4 2025 Longduoduo Co Ltd Earnings Release

    Similar to LDDD

    Picture of 23andMe Holding Co logo

    23andMe Holding Co

    us flag iconPink Sheets on Nasdaq

    Picture of 4Cable TV International logo

    4Cable TV International

    us flag iconPink Sheets on Nasdaq

    Picture of Abattis Bioceuticals logo

    Abattis Bioceuticals

    us flag iconPink Sheets on Nasdaq

    Picture of Accelera Innovations logo

    Accelera Innovations

    us flag iconPink Sheets on Nasdaq

    Picture of Quantum Medical Transport logo

    Quantum Medical Transport

    us flag iconPink Sheets on Nasdaq

    FAQ